The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA3600770
Max Phase: Preclinical
Molecular Formula: C11H10N4S
Molecular Weight: 230.30
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: Cn1cc(-c2ccc3nc(N)sc3c2)cn1
Standard InChI: InChI=1S/C11H10N4S/c1-15-6-8(5-13-15)7-2-3-9-10(4-7)16-11(12)14-9/h2-6H,1H3,(H2,12,14)
Standard InChI Key: RPSUOVPWIGAZEJ-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 230.30Molecular Weight (Monoisotopic): 230.0626AlogP: 2.28#Rotatable Bonds: 1Polar Surface Area: 56.73Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0CX Acidic pKa: CX Basic pKa: 4.34CX LogP: 2.04CX LogD: 2.04Aromatic Rings: 3Heavy Atoms: 16QED Weighted: 0.70Np Likeness Score: -2.41
References 1. Raubo P, Andrews DM, McKelvie JC, Robb GR, Smith JM, Swarbrick ME, Waring MJ.. (2015) Discovery of potent, selective small molecule inhibitors of α-subtype of type III phosphatidylinositol-4-kinase (PI4KIIIα)., 25 (16): [PMID:26087940 ] [10.1016/j.bmcl.2015.05.093 ]
